Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
77.31
-0.49 (-0.63%)
Aug 5, 2026, 12:16 PM EDT - Market open
Disc Medicine Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Disc Medicine stock has a consensus rating of "Strong Buy" and an average price target of $101. The average 1-year stock price forecast is 30.64% higher than the current stock price, while the lowest is $79 (+2.19%) and the highest is $128 (+65.57%).
Price Target: $101 (+30.64%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $88 | Buy | Maintains | $88 | +13.83% | Jul 31, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $111 | Buy | Maintains | $111 | +43.58% | Jul 31, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $83 | Buy | Reiterates | $83 | +7.36% | Jul 31, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $100 | Buy | Maintains | $100 | +29.35% | Jul 30, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
33.69M
EPS This Year
-6.68
from -6.01
EPS Next Year
-7.23
from -6.68
EPS and Forward PE are based on non-GAAP adjusted numbers.